Enzo Biochem CEO Elazar Rabbani's 2020 pay slips 1% to $1.5M

Enzo Biochem reports 2020 executive compensation

By ExecPay News

Published: November 27, 2020

Enzo Biochem reported fiscal year 2020 executive compensation information on November 27, 2020.
In 2020, five executives at Enzo Biochem received on average a compensation package of $778K, a 15% decrease compared to previous year.
Average pay of disclosed executives at Enzo Biochem
Elazar Rabbani, Chief Executive Officer, received $1.5M in total, which decreased by 1% compared to 2019. 41% of Rabbani's compensation, or $611K, was in salary. Rabbani also received $500K in non-equity incentive plan, $112K in option awards, $70K in stock awards, as well as $195K in other compensation.
Barry W. Weiner, President and Treasurer, received a compensation package of $1.3M, which decreased by 1% compared to previous year. 43% of the compensation package, or $542K, was in salary.
Dieter Schapfel, Chief Medical Director,, earned $482K in 2020, a 1% decrease compared to previous year.
Enzo Clinical Labs Kara Cannon, Chief Commercial Officer, received $371K in 2020, which decreases by 2% compared to 2019.
David Bench, Chief Financial Officer, earned $296K in 2020.
Enzo Biochem's fiscal year ends on July 31.

Related executives

Elazar Rabbani

Enzo Biochem

Chief Executive Officer

Barry Weiner

Enzo Biochem

President and Treasurer

David Bench

Enzo Biochem

Chief Financial Officer

Dieter Schapfel

Enzo Biochem

Chief Medical Director,

Enzo Cannon

Enzo Biochem

Chief Commercial Officer

You may also like

Source: SEC filing on November 27, 2020.